insights_auto
Why is BLRX down 5.80%?
Dive Deeperchevron_right
BLRX:NASDAQ
BioLine RX Ltd - ADR
US$1.30
arrow_downward
-5.80%(-0.080) 1D
ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BLRX...
Open
US$1.37
High
US$1.54
Low
US$1.30
Mkt. cap
9.30 ሚ
Avg. vol.
12.80 ሺ
Volume
14.11 ሺ
52-wk high
US$3.95
52-wk low
US$1.30
EPS
-US$1.77
Beta
1.64
Shares outstanding
4.98 ሚ
No. of employees
22
Open
US$1.37
High
US$1.54
Low
US$1.30
Mkt. cap
9.30 ሚ
Avg. vol.
12.80 ሺ
Volume
14.11 ሺ
52-wk high
US$3.95
52-wk low
US$1.30
EPS
-US$1.77
Beta
1.64
Shares outstanding
4.98 ሚ
No. of employees
22
News stories
From web sources and news partners
Foreign Policy Journal
·
ከ1 ሰዓት በፊት
BitMine (NASDAQ: BMNR) Sits On $2.5 Billion Unrealized Loss As Ethereum Slides To July Lows And Crash Warnings Mount
CNBC TV18
·
ከ24 ደቂቃዎች በፊት
Dow, Nasdaq futures edge higher - Here are three most important Wall Street triggers for the week
Bloomberg.com
·
ከ53 ደቂቃዎች በፊት
Asian Stocks Brace for AI Pressure, Data Dump: Markets Wrap
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitebiolinerx.com